“Kala Pharmaceuticals (KALA)… In general, other analysts echo Moussatos’ sentiment. 4 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $20.80, the upside potential comes in at 173%… Revance Therapeutics (RVNC)…… Continue Reading…